Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediate and powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.
Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States.
The Optimizer with Cardiac Contractility Modulation therapy, is CE marked and is in the final stages of clinical evaluation to support FDA approval. See Clinical Data for more information.
Previous versions of the Optimizer, have been implanted in over 3,000 patients with over 10 years of follow-up data available. Clinical trials have shown the device is safe, and significantly improves exercise tolerance and quality of life in treated patients.
The Company’s operations are spread throughout the globe, with corporate headquarters in the Netherlands Antilles, New York based US operations, and Germany based EU operations (Stuttgart) and sales office in Hong Kong.